This monthly feature will help readers keep current on new drugs, new indications, dosage forms, and safety-related changes in labeling or use. Efforts have been made to ensure the accuracy of this information; however, if there are any questions, please let me know at bakerdan@wsu.edu.
Indication: Prevention of respiratory distress syndrome in premature infants at high risk for respiratory distress syndrome
Mechanism of action:
The drug compensates for the deficiency of surfactant, which lowers the surface tension at the air-liquid interface of the alveolar surfaces during respiration and stabilizes the alveoli against collapse at resting transpulmonary pressures. 
